Multiplex assay is a procedure in which various analytes (such as proteins, biomolecules, growth factors, cytokines, chemokines, and others) are profiled by detecting and quantifying them simultaneously. This assay is used to amplify multiple targets in a polymerase chain reaction (PCR) and collect more information from minute quantities of proteins or other analytes in lesser time as compared to conventional methods such as ELISA. Multiplex assays are widely used for pathogen identification, mutation analysis, RNA detection, gene detection analysis, linkage analysis, forensic studies, and others. 

Market Analysis and Insights: Global Nucleic Acid-Based Multiplex Assays Market
The global Nucleic Acid-Based Multiplex Assays market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Nucleic Acid-Based Multiplex Assays market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Nucleic Acid-Based Multiplex Assays market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Nucleic Acid-Based Multiplex Assays market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Nucleic Acid-Based Multiplex Assays market.

Global Nucleic Acid-Based Multiplex Assays Scope and Market Size
Nucleic Acid-Based Multiplex Assays market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Nucleic Acid-Based Multiplex Assays market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Reagents & Consumables
Instruments & Accessories
Software & Services

Segment by Application
Companion Diagnostics
Research & Development
Clinical Diagnostics

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Luminex
Thermo Fisher Scientific
Illumina
Bio-Rad Lab
QIAGEN
BD
Abcam
Seegene
Meso Scale Diagnostics
Randox Laboratories